NTRB
Nutriband IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$44.98M
P/E Ratio
—
EPS
$-2.50
Beta
1.93
52W High
$11.68
52W Low
$3.42
50-Day MA
$3.98
200-Day MA
$5.46
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
370.37
PEG Ratio
—
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $2.28M |
| Gross Profit (TTM) | 763,310 |
| EBITDA | $-9.03M |
| Operating Margin | -1121.00% |
| Return on Equity | -136.10% |
| Return on Assets | -55.20% |
| Revenue/Share (TTM) | $0.20 |
| Book Value | $0.62 |
| Price-to-Book | 7.03 |
| Price-to-Sales (TTM) | 19.74 |
| EV/Revenue | 20.91 |
| EV/EBITDA | -4.55 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -46.40% |
| Shares Outstanding | $12.16M |
| Float | $4.91M |
| % Insiders | 74.50% |
| % Institutions | 2.86% |
Historical Volatility
HV 10-Day
33.80%
HV 20-Day
45.14%
HV 30-Day
52.26%
HV 60-Day
52.73%
HV Rank
3.2%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026